# Skin Problems (Rash, Hand-Foot Syndrome, Radiation Dermatitis) - Oncology Care Pathway

## Objective
Manage chemotherapy and radiation-induced skin toxicities to prevent dose delays/reductions and maintain quality of life. Early intervention prevents progression to severe grades.

## Grading (CTCAE v5.0)

| Grade | Clinical Description | Functional Impact |
|-------|----------------------|-------------------|
| **Grade 1** | Faint erythema or dry desquamation | Asymptomatic or mild symptoms; intervention not indicated |
| **Grade 2** | Moderate to brisk erythema; patchy moist desquamation (mostly confined to skin folds/creases); moderate edema | Limiting instrumental ADL; pain requiring analgesics |
| **Grade 3** | Moist desquamation in areas other than skin folds; bleeding induced by minor trauma/abrasion | Limiting self-care ADL; severe pain; hospitalization indicated |

---

## Assessment & Classification

### 1. EGFR Inhibitor Rash (Acneiform)
- **Causative Agents**: Cetuximab, Panitumumab, Erlotinib, Gefitinib.
- **Appearance**: Papulopustular (acne-like) rash on face, scalp, upper trunk. **NOT** acne (no comedones).
- **Timing**: Usually within 1-2 weeks of starting therapy.

### 2. Hand-Foot Syndrome (Palmar-Plantar Erythrodysesthesia)
- **Causative Agents**: Capecitabine, 5-Fluorouracil (5-FU), Liposomal Doxorubicin, Sunitinib.
- **Appearance**: Erythema, swelling, blistering, peeling on palms and soles.
- **Symptoms**: Tingling, burning, pain, sensitivity to heat.

### 3. Radiation Dermatitis
- **Causative Agents**: External Beam Radiation Therapy (EBRT).
- **Appearance**: Erythema (sunburn-like) → Dry desquamation (peeling) → Moist desquamation (weeping).
- **Location**: Strictly confined to the radiation field.

---

## Management Protocol

### 1. EGFR Inhibitor Rash
- **Prophylaxis (Start Day 1)**:
  - Hydrocortisone 1% cream BID to face/chest.
  - Doxycycline 100mg BID or Minocycline 100mg daily x 6 weeks.
  - Sunscreen (SPF >30, physical blocker).
- **Grade 1**: Continue prophylaxis. Topical clindamycin 1% gel.
- **Grade 2**: Topical steroid (e.g., fluocinonide 0.05%). Oral doxycycline/minocycline.
- **Grade 3**: **Dose Interruption**. Oral corticosteroids (prednisone taper). Consider dermatology referral.

### 2. Hand-Foot Syndrome (HFS)
- **Prevention**: Urea 10-20% cream BID. Avoid friction, heat, tight shoes.
- **Grade 1**: Increase moisturizing (Urea 40% or salicylic acid 6%). Topical high-potency steroid (clobetasol) under occlusion at night.
- **Grade 2**: **Dose Reduction** (consult oncology). Analgesics (NSAIDs/GABA-agonists).
- **Grade 3**: **Dose Interruption** until ≤ Grade 1.

### 3. Radiation Dermatitis
- **General Care**: Gentle cleansing (lukewarm water, mild soap). Pat dry. Avoid petroleum-based products *immediately before* treatment (bolus effect).
- **Grade 1**: Hydrophilic moisturizers (e.g., Calendula, hyaluronic acid) BID.
- **Grade 2**: Silver sulfadiazine cream (Silvadene) or hydrogel dressings for moist areas. Topical steroid (hydrocortisone 2.5%) for itch.
- **Grade 3**: Hydrocolloid or foam dressings. Culture if infection suspected.

---

## Red Flags & Critical Alerts

| Sign/Symptom | Potential Etiology | Action |
|--------------|--------------------|--------|
| **Mucosal involvement + Blistering >30% BSA** | **Stevens-Johnson Syndrome (SJS) / TEN** | **CRITICAL (911)**: Immediate ER evaluation. Stop all suspect medications. |
| **Pustules + Fever + Crusting** | **Superinfection** (Staph/Strep/Herpes) | **URGENT**: Bacterial/Viral culture. Start systemic antimicrobials. |
| **Rapidly spreading erythema + Pain** | **Cellulitis** | **URGENT**: Antibiotics required. |

*Note: BSA (Body Surface Area) estimation: Patient's palm (excluding fingers) ≈ 0.5% BSA; Palm + fingers ≈ 1% BSA.*

---

## Patient Education

### General Skin Care
- **Sun Protection**: SPF 30+, protective clothing. Photosensitivity is common with many chemo agents.
- **Hygiene**: Short, lukewarm showers. Pat dry (do not rub). Use fragrance-free, hypoallergenic soaps.
- **Moisturizing**: Apply thick creams/ointments (not lotions) within 3 minutes of bathing.

### Specific Instructions
- **EGFR Rash**: Do not use over-the-counter acne medications (benzoyl peroxide, salicylic acid) – they dry skin and worsen rash.
- **Hand-Foot Syndrome**: Avoid hot water, vigorous exercise (friction), and tools that press on hands. Wear loose, comfortable shoes.
- **Radiation**: Do not remove ink markings. Avoid shaving the treated area.

---

## Comorbidity Considerations

### Diabetes
- **Impact**: Impaired wound healing; increased risk of superinfection.
- **Management**: Strict glucose control. Lower threshold for antibiotic treatment of skin infections.

### Autoimmune Conditions (Lupus, Psoriasis)
- **Impact**: Increased radiosensitivity; risk of "radiation recall" or flare of underlying condition.
- **Management**: Close monitoring; may require systemic immunosuppression adjustment in coordination with rheumatology.

---

## References
- Singapore Cancer Network Clinical Pathway Guide
- CTCAE v5.0
- MASCC Skin Toxicity Guidelines
